COMMUNIQUÉS West-GlobeNewswire

CLINUVEL delivers second positive financial result
29/08/2018
European revenues re-invested in novel R&D MELBOURNE, Australia, Aug. 29, 2018 (GLOBE NEWSWIRE) -- EXECUTIVE SUMMARY – FINANCIAL YEAR 01 JULY TO 30 JUNE 2017/18 2016/17 Change Total Revenues $25.750m $16.984m 52% [...]
Poseida Therapeutics’ Clinical Update of BCMA-specific CAR-T Program Selected as a Late Breaking Presentation at the 4th Annual CAR-TCR Summit 2018
29/08/2018
Three presentations focus on Poseida’s clinical and preclinical CAR-T programs SAN DIEGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene [...]
Enzymatica AB: Appeal of court ruling on Enzymatica's cold spray in Germany
29/08/2018
Press release August 29, 2018 Appeal of court ruling on Enzymatica's cold spray in Germany Enzymatica's distributor in Germany has appealed to the regional court of Frankfurt on their decision to put restrictions on the [...]
Herantis Pharma Plc's half year financial report January 1 - June 30, 2018 (unaudited)
29/08/2018
Herantis Pharma Plc Company release August 29, 2018 at 9:00am Drug development progresses in randomized trials Herantis Pharma Plc's half year financial report January 1 - June 30, 2018 (unaudited) Highlights in January [...]
Shire plc: Rule 2.9 Announcement
29/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 29 August 2018 [...]
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 21st tranche of investment today
29/08/2018
Amsterdam, The Netherlands - 29 August 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a 21 st Tranche of EUR 300,000 is issued as a private placement of 30 convertible notes (the " [...]
European Commission approves Novartis combination therapy Tafinlar® + Mekinist® for adjuvant treatment of BRAF V600 mutation-positive melanoma
29/08/2018
Approval based on COMBI-AD study demonstrating greater than 50% reduction in risk of disease recurrence or death in stage III melanoma patients More than 50% of stage III melanoma patients are likely to recur to stage [...]
Alcon announces voluntary global market withdrawal of CyPass Micro-Stent for surgical glaucoma
29/08/2018
Decision based on five-year data from COMPASS-XT long-term safety study Alcon advises ophthalmic surgeons to cease further implantation Basel, August 29, 2018 - Reflecting its uncompromising commitment to patient safety [...]
argenx receives feedback from Japan's PMDA on Phase 3 clinical trial and regulatory pathway for efgartigimod in generalized myasthenia gravis
29/08/2018
August 29, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Canada House Wellness Group Reports Fiscal Year 2018 Results
29/08/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“ Canada House ” or the “ Company ”) is [...]
Gradalis® Announces Initiation of Phase 3 Study of Vigil™ in Ewing’s sarcoma
29/08/2018
– The open-label trial will measure progression free survival of participants from date of randomization until first disease progression in the study – – The trial will use product produced from Gradalis’ recently- [...]
Free Health Visits, Available Through Teladoc Health, to Residents Impacted by Hurricane Lane
28/08/2018
Residents and Those Displaced Can Call 855-549-2234 to Access Treatment for Non-Emergency Illnesses PURCHASE, NY, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, is [...]
SeaSpine to Participate in the 13th Annual Wells Fargo Securities Healthcare Conference (corrected time)
28/08/2018
CARLSBAD, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
UPDATE - Endocyte Announces Presentations at the CAR-TCR Summit 2018
28/08/2018
WEST LAFAYETTE, Ind., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that data from the [...]
Assertio Therapeutics and Purdue Pharma Settle Patent Infringement Lawsuit
28/08/2018
Purdue to pay Assertio $62 million in two installments LAKE FOREST, Ill., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that the Company has entered into a settlement [...]
Emergent BioSolutions Joins Effort to Combat National Public Health Threat From Opioid Overdose Through Acquisition of Adapt Pharma and Its Flagship Product NARCAN® (naloxone HCl) Nasal Spray
28/08/2018
Acquisition advances Emergent’s mission, vision and strategic growth plan by: Diversifying and expanding company’s presence within the public health threats market to respond to the opioid crisis, declared a public [...]
Flexion Therapeutics to Present at the 2018 Wells Fargo Healthcare Conference
28/08/2018
BURLINGTON, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that it will present at the 13 th Annual Wells Fargo Securities Healthcare Conference taking place at the [...]
SeaSpine to Participate in the 13th Annual Wells Fargo Securities Healthcare Conference
28/08/2018
CARLSBAD, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
Emisphere’s Proprietary Eligen Technology Supports Novo Nordisk’s Oral Semaglutide
28/08/2018
MHR Converts $963,781 of Emisphere’s Debt to Equity and Emisphere Repays $1,000,000 of Existing Indebtedness held by MHR ROSELAND, N.J., Aug. 28, 2018 (GLOBE NEWSWIRE) -- On August 20, 2018, Novo Nordisk A/S (Novo [...]

Pages